Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Nci–Rtog Translational Program Strategic Guidelines For The Early-Stage Development Of Radiosensitizers, Yaacov Lawrence
Nci–Rtog Translational Program Strategic Guidelines For The Early-Stage Development Of Radiosensitizers, Yaacov Lawrence
Yaacov R. Lawrence
The addition of chemotherapeutic agents to ionizing radiation has improved survival in many malignancies. Cure rates may be further improved by adding novel targeted agents to current radiotherapy or radiochemotherapy regimens. Despite promising laboratory data, progress in the clinical development of new drugs with radiation has been limited. To define and address the problems involved, a collaborative effort between individuals within the translational research program of the Radiation Oncology Therapy Group and the National Cancer Institute was established. We discerned challenges to drug development with radiation including: 1) the limited relevance of preclinical work, 2) the pharmaceutical industry’s diminished interest, …